These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22588231)

  • 21. Combined dyslipidemia in obese children: response to a focused lifestyle approach.
    Pratt RE; Kavey RE; Quinzi D
    J Clin Lipidol; 2014; 8(2):181-6. PubMed ID: 24636177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and management of dyslipidemic children.
    Guardamagna O; Baracco V; Abello F; Bona G
    Minerva Pediatr; 2009 Aug; 61(4):391-8. PubMed ID: 19752848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyslipidemia in the metabolic syndrome: clinical implications and management.
    Hafidh SA; Lavie CJ; Burns BP; Khan SS; Alpert MA
    Minerva Cardioangiol; 2006 Apr; 54(2):215-27. PubMed ID: 16778753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force.
    Haney EM; Huffman LH; Bougatsos C; Freeman M; Steiner RD; Nelson HD
    Pediatrics; 2007 Jul; 120(1):e189-214. PubMed ID: 17606543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic targets in the treatment of dyslipidemia: HDL and non-HDL cholesterol].
    Brea Hernando ÁJ
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():3-6. PubMed ID: 25043539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H; Kamal-Bahl S; Wong ND
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult dyslipidemia prediction is improved by repeated measurements in childhood and young adulthood. The Cardiovascular Risk in Young Finns Study.
    Nuotio J; Oikonen M; Magnussen CG; Viikari JS; Hutri-Kähönen N; Jula A; Thomson R; Sabin MA; Daniels SR; Raitakari OT; Juonala M
    Atherosclerosis; 2015 Apr; 239(2):350-7. PubMed ID: 25682034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular implications of HIV-induced dyslipidemia.
    Giannarelli C; Klein RS; Badimon JJ
    Atherosclerosis; 2011 Dec; 219(2):384-9. PubMed ID: 21722900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence.
    Baller JB; McGinty EE; Azrin ST; Juliano-Bult D; Daumit GL
    BMC Psychiatry; 2015 Mar; 15():55. PubMed ID: 25885367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for lipid disorders.
    Bell DA; Hooper AJ; Bender R; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Pathology; 2012 Feb; 44(2):115-21. PubMed ID: 22198257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dyslipidemia: management using optimal lipid-lowering therapy.
    Ito MK
    Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.
    Ardoin SP; Sandborg C; Schanberg LE
    Lupus; 2007; 16(8):618-26. PubMed ID: 17711898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyslipidemia in menopause: mechanisms and management.
    Schnatz PF; Schnatz JD
    Obstet Gynecol Surv; 2006 Sep; 61(9):608-13. PubMed ID: 16919179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of dyslipidemia in the Iraqi adult population.
    Mula-Abed WA; Chilmeran SK
    Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total lipid management and cardiovascular disease in the dyslipidemia international study.
    Ferrières J; Amber V; Crisan O; Chazelle F; Jünger C; Wood D
    Cardiology; 2013; 125(3):154-63. PubMed ID: 23736147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study.
    Bao W; Srinivasan SR; Wattigney WA; Bao W; Berenson GS
    Arch Intern Med; 1996 Jun; 156(12):1315-20. PubMed ID: 8651840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
    Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
    Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of dyslipidemia with waist to height ratio, waist circumference, and body mass index in Iranian adults.
    Chehrei A; Sadrnia S; Keshteli AH; Daneshmand MA; Rezaei J
    Asia Pac J Clin Nutr; 2007; 16(2):248-53. PubMed ID: 17468079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.